{"id":92869,"date":"2022-12-21T00:00:00","date_gmt":"2022-12-21T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2022\/12\/21\/smartphone-app-may-be-beneficial-for-some-with-bipolar-disorder\/"},"modified":"2022-12-24T01:29:36","modified_gmt":"2022-12-24T01:29:36","slug":"smartphone-app-may-be-beneficial-for-some-with-bipolar-disorder","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2022\/12\/21\/smartphone-app-may-be-beneficial-for-some-with-bipolar-disorder\/","title":{"rendered":"Smartphone App May Be Beneficial for Some With Bipolar Disorder"},"content":{"rendered":"<h3>\n<p>Does not reduce risk of relapse overall, but can reduce relapse risk and manic symptom severity for low-risk individuals<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><\/p>\n<p><b><\/b><\/p>\n<p>WEDNESDAY, Dec. 21, 2022 (HealthDay News) &#8212; A smartphone-based self-management app does not reduce the risk of relapse among patients with bipolar disorder, but can reduce relapse risk and manic symptom severity for low-risk individuals, according to a study published online Dec. 21 in <em>JAMA Psychiatry<\/em>.<\/p>\n<p>Evan H. Goulding, M.D., Ph.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined whether a smartphone-based self-management intervention (LiveWell) can assist individuals with bipolar disorder to maintain wellness. A total of 205 participants with bipolar disorder were randomly assigned to usual care or usual care plus the smartphone-based intervention. Intervention participants had a coach visit, followed by six phone calls over 16 weeks, and they completed daily and weekly check-ins on the app. Adoptive feedback and information for developing a personalized wellness plan was provided by the app, while the coach provided support and the website provided summary data and alerts.<\/p>\n<p>The researchers observed no significant reduction in relapse risk with the smartphone intervention. However, reduced risk of relapse was seen for low-risk individuals, but not for high-risk individuals. For low-risk, but not high-risk, individuals, manic symptom severity was reduced. Depressive symptom severity was reduced with the smartphone-based self-management intervention, and relational quality of life was improved, but no decrease was seen in the percentage time symptomatic.<\/p>\n<p>&#8220;The results of this trial warrant further work to optimize the smartphone intervention and confirm that the intervention decreases relapse risk for individuals in asymptomatic recovery,&#8221; the authors write.<\/p>\n<p>Several authors disclosed financial ties to the pharmaceutical, technology, and publishing industries.<\/p>\n<p><a href=\"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/article-abstract\/2799588\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2022 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Does not reduce risk of relapse overall, but can reduce relapse risk and manic symptom severity for low-risk individuals<\/p>\n","protected":false},"author":6,"featured_media":93013,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-92869","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/92869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=92869"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/92869\/revisions"}],"predecessor-version":[{"id":92953,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/92869\/revisions\/92953"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/93013"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=92869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=92869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=92869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}